Improving Control of Intermittent Exotropia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Improving Control of Intermittent Exotropia — Stella

Recruiting

Back to Intermittent Exotropia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Retina Foundation of the Southwest, Dallas, Texas

Key details

Sponsor

Retina Foundation of the Southwest

Enrollment target

~40 participants

Started

April 2026

Primary completion

February 2028

Age range

4 Years – 10 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov